It is important to gain a more comprehensive understanding of the field to improve the clinical management of HCC patients, especially for decision making regarding anti-VEGF treatments, ICB therapies, and their combination in patients with advanced HCC. Here, VEGFA is linked to hepatocellular carcinoma.